Claro Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Claro Advisors's NVS Position: Q1 2026 in Review
Claro Advisors increased its Novartis (NVS) stake by 9.4% in Q1 2026, buying an estimated $30K and bringing the position to 2,291 shares worth $350K. The position accounts for 0.04% of the portfolio, ranked #332.
Claro Advisors first reported a position in NVS in Q4 2018 and has held it in 23 quarters since. The position peaked at $533K in Q3 2024. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Claro Advisors held 2,291 shares of Novartis worth $350K as of Q1 2026.
- Claro Advisors bought 196 Novartis shares in Q1 2026, an estimated $30K.
- Novartis made up 0.04% of Claro Advisors's portfolio in Q1 2026, its #332 holding.
- Claro Advisors first reported a position in Novartis in Q4 2018 and has held it in 23 quarters since.
- Claro Advisors's Novartis position peaked at $533K in Q3 2024.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.